Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ERibulin in Advanced Solitary Fibrous Tumor, an ItaliaN Sarcoma Group Phase II Study (ERASING)

NCT03840772 is registered in ClinicalTrials.gov with Italian Sarcoma Group as lead sponsor.

NCT NCT03840772
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03840772 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ERibulin in Advanced Solitary Fibrous Tumor, an ItaliaN Sarcoma Group Phase II Study (ERASING)
Lead sponsor
Italian Sarcoma Group
Phase
Phase 2
Overall status
Completed
Start date
July 17, 2019
Completion date
September 18, 2024
Enrollment
16 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

solitary fibrous tumor